1. Home
  2. HRMY vs KAR Comparison

HRMY vs KAR Comparison

Compare HRMY & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • KAR
  • Stock Information
  • Founded
  • HRMY 2017
  • KAR 2006
  • Country
  • HRMY United States
  • KAR United States
  • Employees
  • HRMY N/A
  • KAR N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • KAR Retail-Auto Dealers and Gas Stations
  • Sector
  • HRMY Health Care
  • KAR Consumer Discretionary
  • Exchange
  • HRMY Nasdaq
  • KAR Nasdaq
  • Market Cap
  • HRMY 1.8B
  • KAR 2.4B
  • IPO Year
  • HRMY 2020
  • KAR 2009
  • Fundamental
  • Price
  • HRMY $34.00
  • KAR $25.04
  • Analyst Decision
  • HRMY Strong Buy
  • KAR Buy
  • Analyst Count
  • HRMY 9
  • KAR 4
  • Target Price
  • HRMY $54.44
  • KAR $24.00
  • AVG Volume (30 Days)
  • HRMY 642.5K
  • KAR 931.2K
  • Earning Date
  • HRMY 08-05-2025
  • KAR 08-06-2025
  • Dividend Yield
  • HRMY N/A
  • KAR N/A
  • EPS Growth
  • HRMY 13.13
  • KAR N/A
  • EPS
  • HRMY 2.62
  • KAR 0.58
  • Revenue
  • HRMY $744,852,000.00
  • KAR $1,818,700,000.00
  • Revenue This Year
  • HRMY $20.10
  • KAR $1.93
  • Revenue Next Year
  • HRMY $18.01
  • KAR $6.25
  • P/E Ratio
  • HRMY $13.10
  • KAR $43.03
  • Revenue Growth
  • HRMY 20.62
  • KAR 6.67
  • 52 Week Low
  • HRMY $26.47
  • KAR $15.44
  • 52 Week High
  • HRMY $41.61
  • KAR $26.04
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 58.91
  • KAR 61.93
  • Support Level
  • HRMY $31.70
  • KAR $24.90
  • Resistance Level
  • HRMY $35.08
  • KAR $26.04
  • Average True Range (ATR)
  • HRMY 0.95
  • KAR 0.61
  • MACD
  • HRMY 0.27
  • KAR 0.07
  • Stochastic Oscillator
  • HRMY 71.80
  • KAR 73.35

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About KAR OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

Share on Social Networks: